Clinical Trials Browser

Active not recruiting × Tuberous Sclerosis × Clear all

NCT05044819 2026-03-17

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Phase 4 Active not recruiting

Epilepsies, Myoclonic, Liver Cirrhosis, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT05864846 2026-03-12

EpiCom

Phase 4 Active not recruiting

Behavior, Seizures, Tuberous Sclerosis

NCT02962414 2026-02-03

Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment

Phase 3 Active not recruiting

Seizures, Tuberous Sclerosis

NCT05252585 2026-02-03

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Phase 4 Active not recruiting

Tuberous Sclerosis, Angiomyolipoma

NCT05467397 2026-01-21

Feasibility of [11C]Acetate-PET in LAM and TSC

Phase 1/2 Active not recruiting

7 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT05161494 2025-08-29

GAGA

Active not recruiting

Epileptic Encephalopathy, Early Infantile, 4, Movement Disorders, Tuberous Sclerosis

NCT04198181 2025-01-17

The Effectiveness and Safety of Resective Epilepsy Surgery for TRE

Active not recruiting

Epilepsy, Tuberous Sclerosis

NCT02461459 2024-10-26

Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)

Active not recruiting

Autistic Disorder, Intellectual Disability, Tuberous Sclerosis